New York State Common Retirement Fund’s Maze Therapeutics MAZE Stock Holding History

New York State Common Retirement Fund’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Buy	12,400 +4,200	+51%	+$110K	﹤0.01%	2121
2026 Q1	$245K	Buy	8,200 +1,500	+22%	+$66.2K	﹤0.01%	2157
2025 Q4	$278K	Hold	6,700	–	–	﹤0.01%	2159
2025 Q3	$174K	Buy	6,700 +4,400	+191%	+$74.3K	﹤0.01%	2359
2025 Q2	$28.2K	Hold	2,300	–	–	﹤0.01%	3073
2025 Q1	$25.3K	Buy	+2,300	New	+$27.7K	﹤0.01%	2942

Other funds holding MAZE

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FWP

Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund's MAZE Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Maze Therapeutics (MAZE) stake by 51% in Q2 2026, buying an estimated $110K and bringing the position to 12,400 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

New York State Common Retirement Fund first reported a position in MAZE in Q1 2025 and has held it in 6 quarters since. 22 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

New York State Common Retirement Fund held 12,400 shares of Maze Therapeutics worth $370K as of Q2 2026.
New York State Common Retirement Fund bought 4,200 Maze Therapeutics shares in Q2 2026, an estimated $110K.
Maze Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2121 holding.
New York State Common Retirement Fund first reported a position in Maze Therapeutics in Q1 2025 and has held it in 6 quarters since.
22 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.